BAX Stock Analysis: Buy, Sell, or Hold?

BAX - Baxter International Inc.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$15.85
-0.13 (-0.78%) ▼
5d: -4.61%
30d: -22.21%
90d: -18.24%
HOLD
MODERATE Confidence
Protect Your BAX Gains
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Accumulation

BAX is down 13.2% this week, but smart money is accumulating calls. Top strike: $22.5 2026-05-15 with 1,773 OI. Call ratio: 60% View Scanner →

Strength: 7.6/10

Get Alerted When BAX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: BAX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$23.75
Based on 5.6% avg growth
INTRINSIC VALUE TODAY
$14.75
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.8x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: BAX is currently trading at $15.85, which is considered oversold relative to its 30-day fair value range of $16.79 to $20.42. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.8) compared to its historical average (8.8). Remarkably, the market is currently pricing in an annual earnings decline of 4.1% over the next few years. This pessimistic expectation contrasts with the company's recent 237.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, BAX is in a strong downtrend. The price is currently testing key support at $16.08. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: BAX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $22.19 (+39.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $16.79 - $20.42
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.1%

Protect Your Profits

Holding BAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 39.0% below Wall St target ($22.19)

Fair Price Analysis

30-Day Fair Range $16.79 - $20.42
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $16.08
Resistance Level $17.84
Current Trend Strong Downtrend
Technical data as of Mar 27, 2026

Fundamental Context

Forward P/E (Next Year Est.) 7.79
Wall Street Target $22.19 (+39.0%)
Revenue Growth (YoY) 8.0%
Earnings Growth (YoY) 237.9%
Profit Margin -8.5%
Valuation Discount vs History -4.1% cheaper
PE vs Historical 7.8 vs 8.8 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -4.1% (market-implied from PE analysis)
1-Year Target $15.32 (-4%)
2-Year Target $14.69 (-8%)
3-Year Target $14.09 (-12%)
3-Yr Target (if PE normalizes) (PE: 8→9) $15.92 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.4, Growth: 7.3%) $56.68 (+255%)
Base: (SPY PE: 7.8, Growth: 7.3%) $19.70 (+23%)
Bear: (PE: 6.6, Growth: 7.3%) $16.75 (+5%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.8 to 8.8
Stabilization Target: $18.05 (+13.0%)
PE Expansion Potential: +13.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 10:10 AM ET
Data refreshes hourly during market hours. Next update: 11:10 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
5
Buys
3
Sells
+
Net
NEUTRAL
Recent Transactions
Michael T. McCaul BUY 2026-02-17
Ro Khanna BUY 2026-02-17
Ro Khanna BUY 2026-01-29

Unlock Insider Activity

See real-time buying/selling by company executives for BAX.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$607 51 HOLD
ALC
Alcon AG
STRONG BUY
27 analysts
$94 55 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$186 54 HOLD
WST
West Pharmaceutical Serv…
STRONG BUY
13 analysts
$318 63 BUY
RMD
ResMed Inc
BUY
19 analysts
$297 61 BUY

Advanced BAX Option Strategies

Professional options setups generated by AI based on today's BAX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BAX

BAX Technical Chart BAX Price Prediction BAX Earnings Date BAX Investment Advisor BAX Fair Price Analyzer BAX Options Advisor BAX Options Chain BAX Options Analysis BAX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals